Cyclica, a leading biotechnology company that commercialized Ligand Express announced its novel, first-in-class drug design technology, Ligand Design on stage at the Collision Conference in Toronto. This revolutionary platform empowers scientists in the pharmaceutical industry […]
Transgene announces that the last patient has been included in the phase 2 trial evaluating TG4010 in combination with Opdivo (nivolumab) and chemotherapy as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) […]
Eli Lilly has announced the market launch of a half-price, generic version of its Humalog insulin, Called Insulin Lispro Injection, the product is available in a vial or within a KwikPen. Insulin Lispro can be […]
MEP Deirdre Clune officially opened the new ILC Dover manufacturing facility in Blarney Business Park, Cork alongside ILC Dover CEO and President Fran DiNuzzo. The state-of-the-art manufacturing facility equipped with 10,500 sq ft of clean […]
SMi Group are delighted to announce that industry expert Mary-Beth Joshi, Director, Duke University Medial Centre will lead a pre-conference workshop in London on the 24th September. Workshop Overview: Workshop B – Tuesday 24th September […]